William Blake Martin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William Blake Martin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ramakrishna Venugopalan
University of Alabama at Birmingham, Department of Biomedical Engineering, 1075 13th St. S, Suite 370 (W.B.M.), Department of Physics, 1300 University Boulevard, Room 310, Campbell Hall (S.M.), Birmingham, Alabama 35294; and Neuro Modulation R&D, Codman and Shurtleff, A J&J Company, 325 Paramount Drive, Raynham, Massachusetts 02767-0350
3 shared publicationsSergey Mirov
University of Alabama at Birmingham, Department of Biomedical Engineering, 1075 13th St. S, Suite 370 (W.B.M.), Department of Physics, 1300 University Boulevard, Room 310, Campbell Hall (S.M.), Birmingham, Alabama 35294; and Neuro Modulation R&D, Codman and Shurtleff, A J&J Company, 325 Paramount Drive, Raynham, Massachusetts 02767-0350
3 shared publications- Andrew M. Shaw
Biosciences, University of Exeter, Stocker Road, Exeter, EX4 4QD, UK
1 shared publication D. Martyshkin
1 shared publicationDmitri Martyshkin
University of Alabama at Birmingham, Department of Physics, 1300 University Boulevard, Room 310, Campbell Hall, Birmingham, Alabama 35294-4440
1 shared publicationR. Venugopalan
1 shared publication
Latest Publications
- Open Access
- 16 October 2019
- Published by Hindawi Limited in BioMed Research International
- Vol. 2019, 1-7
Methods of Cryoprotectant Preservation: Allogeneic Cellular Bone Grafts and Potential Effects
Debridement of the bone surface during a surgical fusion procedure initiates an injury response promoting a healing cascade of molecular mediators released over time. Autologous grafts offer natural scaffolding to fill the bone void and to provide local bone cells. Commercial bone grafting products such as allografts, synthetic bone mineral products, etc., are used to supplement or to replace autologous grafts by supporting osteoinductivity, osteoconductivity, and osteogenesis at the surgical site. To assure osteogenic potential, preservation of allogeneic cells with cryoprotectants has been developed to allow for long-term storage and thus delivery of viable bone cells to the surgical site. Dimethyl sulfoxide (DMSO) is an intracellular cryoprotectant commonly used because it provides good viability of the cells post-thaw. However, there is known cytotoxicity reported for DMSO when cells are stored above cryogenic temperatures. For most cellular bone graft products, the cryoprotectant is incorporated with the cells into the other mineralized bone and demineralized bone components. During thawing, the DMSO may not be sufficiently removed from allograft products compared to its use in a cell suspension where removal by washing and centrifugation is available. Therefore, both the allogeneic cell types in the bone grafting product and the local cell types at the bone grafting site could be affected as cytotoxicity varies by cell type and by DMSO content according to reported studies. Overcoming cytotoxicity may be an additional challenge in the formation of bone at a wound or surgical site. Other extracellular cryoprotectants have been explored as alternatives to DMSO which preserve without entering the cell membrane, thereby providing good cellular viability post-thaw and might abrogate the cytotoxicity concerns.
- 16 October 2019
- Published by Hindawi Limited in BioMed Research International
- Vol. 2019, 1-7
Open AccessMethods of Cryoprotectant Preservation: Allogeneic Cellular Bone Grafts and Potential Effects
Debridement of the bone surface during a surgical fusion procedure initiates an injury response promoting a healing cascade of molecular mediators released over time. Autologous grafts offer natural scaffolding to fill the bone void and to provide local bone cells. Commercial bone grafting products such as allografts, synthetic bone mineral products, etc., are used to supplement or to replace autologous grafts by supporting osteoinductivity, osteoconductivity, and osteogenesis at the surgical site. To assure osteogenic potential, preservation of allogeneic cells with cryoprotectants has been developed to allow for long-term storage and thus delivery of viable bone cells to the surgical site. Dimethyl sulfoxide (DMSO) is an intracellular cryoprotectant commonly used because it provides good viability of the cells post-thaw. However, there is known cytotoxicity reported for DMSO when cells are stored above cryogenic temperatures. For most cellular bone graft products, the cryoprotectant is incorporated with the cells into the other mineralized bone and demineralized bone components. During thawing, the DMSO may not be sufficiently removed from allograft products compared to its use in a cell suspension where removal by washing and centrifugation is available. Therefore, both the allogeneic cell types in the bone grafting product and the local cell types at the bone grafting site could be affected as cytotoxicity varies by cell type and by DMSO content according to reported studies. Overcoming cytotoxicity may be an additional challenge in the formation of bone at a wound or surgical site. Other extracellular cryoprotectants have been explored as alternatives to DMSO which preserve without entering the cell membrane, thereby providing good cellular viability post-thaw and might abrogate the cytotoxicity concerns.
- 3 February 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- Vol. 1, 2345-2348
Evanescent cavity ring-down spectroscopy (e-CRDS) of hemoglobin absorption at the silica-water interface
The absorption of hemoglobin (Hb) from controlled urine samples was observed using the technique of evanescent cavity ring-down spectroscopy (e-CRDS). A room temperature, alexandrite laser pumped LiF:F/sub 2/+ color-center pulsed laser was used to excite Hb at 425 nm. A minimum absorbance level of 2.57 /spl times/ 10/sup -4/ was achieved corresponding to a minimum detectable concentration of Hb in urine of 5.8 nM. These levels could have advantages in the diagnosis of hemoglobinurea. The formation of layers of Hb upon the silica surface allowed for an increased sensitivity for smaller concentrations of Hb than would be expected for only a free floating solution. The formation of the layers also suggested a higher binding constant of Hb to the silica surface than between other layers of Hb molecules. Future studies are underway to understand the effects of salinity on the observed absorption due to the competitive binding of Na/sup +/ to the surface. Absorption isotherm modeling will also be used to better understand the development of layers upon the surface.
- 3 February 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- Vol. 1, 2345-2348
Evanescent cavity ring-down spectroscopy (e-CRDS) of hemoglobin absorption at the silica-water interface
The absorption of hemoglobin (Hb) from controlled urine samples was observed using the technique of evanescent cavity ring-down spectroscopy (e-CRDS). A room temperature, alexandrite laser pumped LiF:F/sub 2/+ color-center pulsed laser was used to excite Hb at 425 nm. A minimum absorbance level of 2.57 /spl times/ 10/sup -4/ was achieved corresponding to a minimum detectable concentration of Hb in urine of 5.8 nM. These levels could have advantages in the diagnosis of hemoglobinurea. The formation of layers of Hb upon the silica surface allowed for an increased sensitivity for smaller concentrations of Hb than would be expected for only a free floating solution. The formation of the layers also suggested a higher binding constant of Hb to the silica surface than between other layers of Hb molecules. Future studies are underway to understand the effects of salinity on the observed absorption due to the competitive binding of Na/sup +/ to the surface. Absorption isotherm modeling will also be used to better understand the development of layers upon the surface.
- 1 July 2005
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 59 (7) , 881-884
Middle Infrared, Quantum Cascade Laser Optoelectronic Absorption System for Monitoring Glucose in Serum
Advances in middle infrared technology are leading researchers beyond the Fourier transform infrared spectrometer and to the quantum cascade laser. While most research focuses on gas-phase detection, recent research explores its use for condensed-phase matter studies. This work investigates its use for monitoring biologically relevant samples of glucose in serum. Samples with physiological glucose concentrations were monitored with a laser at 1036 cm −1 . A 0.992 R 2 linearity value was observed. In addition, using another laser at 1194 cm −1 as a measure of the background spectroscopic characteristics, a linearity of 0.998 R 2 was observed. The average predictive standard errors of the mean (SEM) were 32.5 and 24.7 mg/dL, respectively, for each method. Quantum cascade lasers could be used to develop middle infrared devices for uses beyond the confines of the laboratory.
- 1 July 2005
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 59 (7) , 881-884
Middle Infrared, Quantum Cascade Laser Optoelectronic Absorption System for Monitoring Glucose in Serum
Advances in middle infrared technology are leading researchers beyond the Fourier transform infrared spectrometer and to the quantum cascade laser. While most research focuses on gas-phase detection, recent research explores its use for condensed-phase matter studies. This work investigates its use for monitoring biologically relevant samples of glucose in serum. Samples with physiological glucose concentrations were monitored with a laser at 1036 cm −1 . A 0.992 R 2 linearity value was observed. In addition, using another laser at 1194 cm −1 as a measure of the background spectroscopic characteristics, a linearity of 0.998 R 2 was observed. The average predictive standard errors of the mean (SEM) were 32.5 and 24.7 mg/dL, respectively, for each method. Quantum cascade lasers could be used to develop middle infrared devices for uses beyond the confines of the laboratory.
- 1 January 2005
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 10 (2) , 024025-0240257
Hemoglobin adsorption isotherm at the silica-water interface with evanescent wave cavity ring-down spectroscopy
Evanescent wave cavity ring-down spectroscopy (EW-CRDS) is used to observe the adsorption isotherm for hemoglobin (Hb) from controlled urine samples to assess the potential for rapid diagnosis in hemoglobinuria. The absorbance of Hb at 425 nm is monitored using an alexandrite laser-pumped, room temperature, color-center pulsed laser. A minimum absorbance detection level of is achieved, corresponding to a minimum detectable concentration of Hb in urea of 5.8 nM. A multilayered Hb biofilm is formed, and a minimum of eight layers are required to model the adsorption isotherm, allowing for cooperative binding within the layers and extending 56 nm into the interface. A binding constant for Hb to silica is derived, and a binding constant for Hb to Hb in subsequent layers is determined to be Stoichiometric binding coefficients of 1.530±0.981 for layer one and 1.792±0.162 for subsequent layers suggest that cooperative binding both to the silica surface and between the layers of the biofilm is important. © 2005 Society of Photo-Optical Instrumentation Engineers.- 1 January 2005
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 10 (2) , 024025-0240257
Hemoglobin adsorption isotherm at the silica-water interface with evanescent wave cavity ring-down spectroscopy
Evanescent wave cavity ring-down spectroscopy (EW-CRDS) is used to observe the adsorption isotherm for hemoglobin (Hb) from controlled urine samples to assess the potential for rapid diagnosis in hemoglobinuria. The absorbance of Hb at 425 nm is monitored using an alexandrite laser-pumped, room temperature, color-center pulsed laser. A minimum absorbance detection level of is achieved, corresponding to a minimum detectable concentration of Hb in urea of 5.8 nM. A multilayered Hb biofilm is formed, and a minimum of eight layers are required to model the adsorption isotherm, allowing for cooperative binding within the layers and extending 56 nm into the interface. A binding constant for Hb to silica is derived, and a binding constant for Hb to Hb in subsequent layers is determined to be Stoichiometric binding coefficients of 1.530±0.981 for layer one and 1.792±0.162 for subsequent layers suggest that cooperative binding both to the silica surface and between the layers of the biofilm is important. © 2005 Society of Photo-Optical Instrumentation Engineers.- Open Access
- 1 January 2002
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 7 (4) , 613-617
Using two discrete frequencies within the middle infrared to quantitatively determine glucose in serum
Tight glucose monitoring is essential for the reduction of diabetic complications. This research investigated the changes of absorption spectra observed in serum at three prominent glucose absorption peaks in the middle infrared using a demountable liquid, transmission cell. Two frequencies of light were used to determine the glucose absorption: one at 1193 to determine the background water absorption and the other at one of the characteristic peaks (1035, 1080, and 1109 The peak at 1035 was best for quantitative determination with a standard of error of 20.6 mg/dl (1.1 mmol/L). While interference from other serum constituents could cause problems, urea and albumin—two constituents known to have close absorption peaks—were determined to have no effect on the ability to determine the glucose levels at 1035 © 2002 Society of Photo-Optical Instrumentation Engineers.- 1 January 2002
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 7 (4) , 613-617
Open AccessUsing two discrete frequencies within the middle infrared to quantitatively determine glucose in serum
Tight glucose monitoring is essential for the reduction of diabetic complications. This research investigated the changes of absorption spectra observed in serum at three prominent glucose absorption peaks in the middle infrared using a demountable liquid, transmission cell. Two frequencies of light were used to determine the glucose absorption: one at 1193 to determine the background water absorption and the other at one of the characteristic peaks (1035, 1080, and 1109 The peak at 1035 was best for quantitative determination with a standard of error of 20.6 mg/dl (1.1 mmol/L). While interference from other serum constituents could cause problems, urea and albumin—two constituents known to have close absorption peaks—were determined to have no effect on the ability to determine the glucose levels at 1035 © 2002 Society of Photo-Optical Instrumentation Engineers.